Osteologix, Inc.·4

Jun 11, 5:20 PM ET

Schonharting Florian 4

4 · Osteologix, Inc. · Filed Jun 11, 2010

Insider Transaction Report

Form 4
Period: 2010-06-11
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2010-06-11$0.50/sh+1,494,532$749,9566,517,264 total(indirect: By Nordic Biotech Opportunity Fund K/S)
Holdings
  • Common Stock, par value $0.0001 per share

    (indirect: By Nordic Biotech K/S)
    15,133,061
  • Common Stock, par value $0.0001 per share

    20,000
Footnotes (2)
  • [F1]Mr. Sch?nharting is a principal of Nordic Biotech Opportunity Fund K/S, which is the record holder of 6,517,264 shares of Common Stock. Mr. Sch?nharting disclaims beneficial ownership of the securities held by Nordic Biotech Opportunity Fund K/S, except to the extent of his pecuniary interest therein.
  • [F2]Mr. Sch?nharting is a principal of Nordic Biotech K/S, which is the record holder of 15,133,061 shares of Common Stock. Mr. Sch?nharting disclaims beneficial ownership of the securities held by Nordic Biotech K/S, except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT